ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
BACKGROUND:Aldehyde dehydrogenase 1A1 (ALDH1A1) encodes an enzyme that oxidizes aldehydes to their corresponding carboxylic acids. In colorectal cancer ALDH1A1 marks cancer stem cells and plays putative roles in tumor progression and drug resistance. However, the potential value of ALDH1A1 as a diag...
Main Authors: | Lizet M van der Waals, Inne H M Borel Rinkes, Onno Kranenburg |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6181398?pdf=render |
Similar Items
-
Differential Notch and TGFβ Signaling in Primary Colorectal Tumors and Their Corresponding Metastases
by: Liesbeth M. Veenendaal, et al.
Published: (2008-01-01) -
Low expression of aldehyde deyhdrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer
by: Dutta Shamik, et al.
Published: (2011-06-01) -
Upregulated NLGN1 predicts poor survival in colorectal cancer
by: Qian Yu, et al.
Published: (2021-08-01) -
Impact of sidedness of colorectal cancer on tumor immunity.
by: Chie Takasu, et al.
Published: (2020-01-01) -
The combination of aldehyde dehydrogenase 1 (ALDH1) and CD44 is associated with poor outcomes in endometrial cancer.
by: Hsin-Hui Huang, et al.
Published: (2018-01-01)